Samuel I. Fink, MD, FACP, internal medicine specialist in private practice in Tarzana, California, and his daughter, Sarrica Fink, RN, previously in practice at Cedar Sinai Medical Center…
Jenny C. Yip, PsyD, ABPP, shares advice for HCPs who may be struggling with anxiety or depression as a result of months of practicing medicine and managing personal…
NEW YORK (Reuters Health) – Patients who are admitted on a weekend for bleeding peptic ulcers have worse survival than their peers admitted on a weekday, according to…
NEW YORK (Reuters Health) – By reducing dyspnea and increasing exercise tolerance, breathing a mixture of 60% helium and 40% oxygen augments the benefits of physical rehabilitation in…
NEW YORK (Reuters Health) – Another study has shown an interaction between clopidogrel and proton pump inhibitors. The findings indicate that patients who receive clopidogrel and a PPI…
NEW YORK (Reuters Health) – An investigation prompted by the discovery of vaccine-derived poliovirus (VDPV) infection in a hospitalized immunodeficient infant from an Amish community in Minnesota uncovered…
NEW YORK (Reuters Health) – Although it is safe, low-dose vitamin K used to treat warfarin recipients with high INRs (international normalized ratios) does not reduce episodes of…
NEW YORK (Reuters Health) – Reducing blood pressure with the drug combination perindopril-indapamide reduces renal events in patients with type 2 diabetes, even when the initial blood pressure…
NEW YORK (Reuters Health) – New research suggests that B-cell clones may be a useful early marker for chronic lymphocytic leukemia (CLL) since they are found in nearly…
NEW YORK (Reuters Health) – In patients with diffuse cutaneous systemic sclerosis (dcSSc), treatment with rituximab depletes B cells in the peripheral circulation and in skin, with few…
NEW YORK (Reuters Health) – The prognosis for patients with systemic sclerosis complicated by pulmonary hypertension is “grim,” particularly among African Americans and those with interstitial lung disease,…
NEW YORK (Reuters Health) – An ultrasensitive assessment of HIV-RNA levels in HAART-treated patients with subclinical viral loads reveals that nevirapine-based regimens are more effective in this setting…